{{Rsnum
|rsid=10507380
|Chromosome=13
|position=27305389
|Orientation=plus
|GMAF=0.06657
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 67.7 | 27.7 | 4.6
| HCB | 99.3 | 0.7 | 0.0
| JPT | 98.2 | 1.8 | 0.0
| YRI | 97.3 | 2.7 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 99.3 | 0.7 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs10507380
|PubMedID=17903306
|Condition=Electrocardiographic traits
|Gene=RPL21
|Risk Allele=
|pValue=8.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs10507380
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903306; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association study of electrocardiographic and heart rate variability traits: the Framingham Heart Study (Initial Sample Size: 548-1,175 individuals, depending on measure (Framingham); Replication Sample Size: NR). This variant is associated with Electrocardiographic traits.
|Drugs=
|Drug Classes=
|Diseases=Cardiovascular Diseases
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356508
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10507380
|overall_frequency_n=11
|overall_frequency_d=128
|overall_frequency=0.0859375
|n_genomes=8
|n_genomes_annotated=0
|n_haplomes=8
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}